About
Musculoskeletal injuries are a multi-billion dollar market in the US. MedTexel has a revolutionary bio-mimetic technology platform for treating hard and soft tissue skeletal injuries. Our patent pending treatment guides stem cell activity and safely accelerates tissue repair by stimulating our inherent response to injury.